BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andreadou I, Cabrera-Fuentes HA, Devaux Y, Frangogiannis NG, Frantz S, Guzik T, Liehn EA, Gomes CPC, Schulz R, Hausenloy DJ. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities. Cardiovasc Res 2019;115:1117-30. [PMID: 30825305 DOI: 10.1093/cvr/cvz050] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 27.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Qu H, Yang T, Liu Q, Zhou H. Astragaloside IV attenuate MI-induced myocardial fibrosis and cardiac remodeling by inhibiting ROS/caspase-1/GSDMD signaling pathway. Cell Cycle 2022;:1-14. [PMID: 35770948 DOI: 10.1080/15384101.2022.2093598] [Reference Citation Analysis]
2 Yao Y, Li A, Wang S, Lu Y, Xie J, Zhang H, Zhang D, Ding J, Wang Z, Tu C, Shen L, Zhuang L, Zhu Y, Gao C. Multifunctional elastomer cardiac patches for preventing left ventricle remodeling after myocardial infarction in vivo. Biomaterials 2022;282:121382. [DOI: 10.1016/j.biomaterials.2022.121382] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Besse S, Nadaud S, Balse E, Pavoine C. Early Protective Role of Inflammation in Cardiac Remodeling and Heart Failure: Focus on TNFα and Resident Macrophages. Cells 2022;11:1249. [DOI: 10.3390/cells11071249] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pluijmert NJ, Atsma DE, Quax PHA. Post-ischemic Myocardial Inflammatory Response: A Complex and Dynamic Process Susceptible to Immunomodulatory Therapies. Front Cardiovasc Med 2021;8:647785. [PMID: 33996944 DOI: 10.3389/fcvm.2021.647785] [Reference Citation Analysis]
5 Penna C, Comità S, Tullio F, Alloatti G, Pagliaro P. Challenges facing the clinical translation of cardioprotection: 35 years after the discovery of ischemic preconditioning. Vascular Pharmacology 2022. [DOI: 10.1016/j.vph.2022.106995] [Reference Citation Analysis]
6 Yap J, Cabrera-Fuentes HA, Irei J, Hausenloy DJ, Boisvert WA. Role of Macrophages in Cardioprotection. Int J Mol Sci 2019;20:E2474. [PMID: 31109146 DOI: 10.3390/ijms20102474] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
7 Mikolajczyk TP, Szczepaniak P, Vidler F, Maffia P, Graham GJ, Guzik TJ. Role of inflammatory chemokines in hypertension. Pharmacol Ther 2021;223:107799. [PMID: 33359600 DOI: 10.1016/j.pharmthera.2020.107799] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Pietropaoli D, Monaco A, D'Aiuto F, Muñoz Aguilera E, Ortu E, Giannoni M, Czesnikiewicz-Guzik M, Guzik TJ, Ferri C, Del Pinto R. Active gingival inflammation is linked to hypertension. J Hypertens 2020;38:2018-27. [PMID: 32890278 DOI: 10.1097/HJH.0000000000002514] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 17.0] [Reference Citation Analysis]
9 Chong SY, Zharkova O, Yatim SMJM, Wang X, Lim XC, Huang C, Tan CY, Jiang J, Ye L, Tan MS, Angeli V, Versteeg HH, Dewerchin M, Carmeliet P, Lam CSP, Chan MY, de Kleijn DPV, Wang JW. Tissue factor cytoplasmic domain exacerbates post-infarct left ventricular remodeling via orchestrating cardiac inflammation and angiogenesis. Theranostics 2021;11:9243-61. [PMID: 34646369 DOI: 10.7150/thno.63354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Pluijmert NJ, Bart CI, Bax WH, Quax PHA, Atsma DE. Effects on cardiac function, remodeling and inflammation following myocardial ischemia-reperfusion injury or unreperfused myocardial infarction in hypercholesterolemic APOE*3-Leiden mice. Sci Rep 2020;10:16601. [PMID: 33024178 DOI: 10.1038/s41598-020-73608-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wang Y, Xian H. Identifying Genes Related to Acute Myocardial Infarction Based on Network Control Capability. Genes 2022;13:1238. [DOI: 10.3390/genes13071238] [Reference Citation Analysis]
12 Tsoumani M, Georgoulis A, Nikolaou P, Kostopoulos IV, Dermintzoglou T, Papatheodorou I, Zoga A, Efentakis P, Konstantinou M, Gikas E, Kostomitsopoulos N, Papapetropoulos A, Lazou A, Skaltsounis AL, Hausenloy DJ, Tsitsilonis O, Tseti I, Di Lisa F, Iliodromitis EK, Andreadou I. Acute administration of the olive constituent, oleuropein, combined with ischemic postconditioning increases myocardial protection by modulating oxidative defense. Free Radical Biology and Medicine 2021;166:18-32. [DOI: 10.1016/j.freeradbiomed.2021.02.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, Hare JM, Heidecker B, Heymans S, Hübner N, Kelle S, Klingel K, Maatz H, Parwani AS, Spillmann F, Starling RC, Tsutsui H, Seferovic P, Van Linthout S. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol 2021;18:169-93. [PMID: 33046850 DOI: 10.1038/s41569-020-00435-x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 28.5] [Reference Citation Analysis]
14 Wang Y, Yuan M, Ma Y, Shao C, Wang Y, Qi M, Ren B, Gao D. The Admission (Neutrophil+Monocyte)/Lymphocyte Ratio Is an Independent Predictor for In-Hospital Mortality in Patients With Acute Myocardial Infarction. Front Cardiovasc Med 2022;9:870176. [DOI: 10.3389/fcvm.2022.870176] [Reference Citation Analysis]
15 Zhong Y, Yu X, Li X, Zhou H, Wang Y. Augmented early aged neutrophil infiltration contributes to late remodeling post myocardial infarction. Microvasc Res 2022;139:104268. [PMID: 34728225 DOI: 10.1016/j.mvr.2021.104268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Li Q, Huang Z, Wang Q, Gao J, Chen J, Tan H, Li S, Wang Z, Weng X, Yang H, Pang Z, Song Y, Qian J, Ge J. Targeted immunomodulation therapy for cardiac repair by platelet membrane engineering extracellular vesicles via hitching peripheral monocytes. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lazou A, Ikonomidis I, Bartekova M, Benedek T, Makavos G, Palioura D, Cabrera Fuentes H, Andreadou I. Chronic inflammatory diseases, myocardial function and cardioprotection. Br J Pharmacol 2020;177:5357-74. [PMID: 31943142 DOI: 10.1111/bph.14975] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
18 Pearce L, Davidson SM, Yellon DM. Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response. Basic Res Cardiol 2021;116:12. [PMID: 33629195 DOI: 10.1007/s00395-021-00852-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Lafuse WP, Wozniak DJ, Rajaram MVS. Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair. Cells 2020;10:E51. [PMID: 33396359 DOI: 10.3390/cells10010051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Smagul S, Kim Y, Smagulova A, Raziyeva K, Nurkesh A, Saparov A. Biomaterials Loaded with Growth Factors/Cytokines and Stem Cells for Cardiac Tissue Regeneration. Int J Mol Sci 2020;21:E5952. [PMID: 32824966 DOI: 10.3390/ijms21175952] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
21 Xiong W, Zhou R, Qu Y, Yang Y, Wang Z, Song N, Liang R, Qian J. Dexmedetomidine preconditioning mitigates myocardial ischemia/reperfusion injury via inhibition of mast cell degranulation. Biomed Pharmacother 2021;141:111853. [PMID: 34237593 DOI: 10.1016/j.biopha.2021.111853] [Reference Citation Analysis]
22 Du J, Zhang J. Scientific highlights from the Great Wall International Congress of Cardiology 2019. Cardiovasc Res 2020;116:e19-20. [PMID: 31850501 DOI: 10.1093/cvr/cvz324] [Reference Citation Analysis]
23 Davidson SM, Andreadou I, Barile L, Birnbaum Y, Cabrera-Fuentes HA, Cohen MV, Downey JM, Girao H, Pagliaro P, Penna C, Pernow J, Preissner KT, Ferdinandy P. Circulating blood cells and extracellular vesicles in acute cardioprotection. Cardiovasc Res 2019;115:1156-66. [PMID: 30590395 DOI: 10.1093/cvr/cvy314] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 27.0] [Reference Citation Analysis]
24 Klingenberg R, Stähli BE, Heg D, Denegri A, Manka R, Kapos I, von Eckardstein A, Carballo D, Hamm CW, Vietheer J, Rolf A, Landmesser U, Mach F, Moccetti T, Jung C, Kelm M, Münzel T, Pedrazzini G, Räber L, Windecker S, Matter CM, Ruschitzka F, Lüscher TF. Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial. Am Heart J 2022;247:33-41. [PMID: 35092722 DOI: 10.1016/j.ahj.2022.01.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
25 de Dios E, Rios-Navarro C, Pérez-Solé N, Gavara J, Marcos-Garcés V, Forteza MJ, Oltra R, Vila JM, Chorro FJ, Bodi V. Overexpression of genes involved in lymphocyte activation and regulation are associated with reduced CRM-derived cardiac remodelling after STEMI. Int Immunopharmacol 2021;95:107490. [PMID: 33677257 DOI: 10.1016/j.intimp.2021.107490] [Reference Citation Analysis]
26 Sánchez-Hernández CD, Torres-Alarcón LA, González-Cortés A, Peón AN. Ischemia/Reperfusion Injury: Pathophysiology, Current Clinical Management, and Potential Preventive Approaches. Mediators Inflamm 2020;2020:8405370. [PMID: 32410868 DOI: 10.1155/2020/8405370] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
27 Bienvenu LA, Wang X, Peter K. Prime time viewing of the ischaemic heart: new technologies allow imaging and flow assessment of the microvasculature in the beating heart. Cardiovasc Res 2019;115:1817-9. [PMID: 31270528 DOI: 10.1093/cvr/cvz168] [Reference Citation Analysis]
28 Hausenloy DJ, Heusch G. Translating Cardioprotection for Patient Benefit. Journal of the American College of Cardiology 2019;73:2001-3. [DOI: 10.1016/j.jacc.2019.03.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
29 Nielsen MB, Ravlo K, Eijken M, Krogstrup NV, Bue Svendsen M, Abdel-Halim C, Steen Petersen M, Birn H, Oltean M, Jespersen B, Møller BK. Dynamics of circulating dendritic cells and cytokines after kidney transplantation-No effect of remote ischaemic conditioning. Clin Exp Immunol 2021;206:226-36. [PMID: 34473350 DOI: 10.1111/cei.13658] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Lu S, Tian Y, Luo Y, Xu X, Ge W, Sun G, Sun X. Iminostilbene, a novel small-molecule modulator of PKM2, suppresses macrophage inflammation in myocardial ischemia-reperfusion injury. J Adv Res 2021;29:83-94. [PMID: 33842007 DOI: 10.1016/j.jare.2020.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
31 Richardson WJ, Rogers JD, Spinale FG. Does the Heart Want What It Wants? A Case for Self-Adapting, Mechano-Sensitive Therapies After Infarction. Front Cardiovasc Med 2021;8:705100. [PMID: 34568449 DOI: 10.3389/fcvm.2021.705100] [Reference Citation Analysis]
32 Yang D, Liu HQ, Liu FY, Tang N, Guo Z, Ma SQ, An P, Wang MY, Wu HM, Yang Z, Fan D, Tang QZ. Critical roles of macrophages in pressure overload-induced cardiac remodeling. J Mol Med (Berl) 2021;99:33-46. [PMID: 33130927 DOI: 10.1007/s00109-020-02002-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Wang ZK, Chen RR, Li JH, Chen JY, Li W, Niu XL, Wang FF, Wang J, Yang JX. Puerarin protects against myocardial ischemia/reperfusion injury by inhibiting inflammation and the NLRP3 inflammasome: The role of the SIRT1/NF-κB pathway. Int Immunopharmacol 2020;89:107086. [PMID: 33068868 DOI: 10.1016/j.intimp.2020.107086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
34 Contessotto P, Pandit A. Therapies to prevent post-infarction remodelling: From repair to regeneration. Biomaterials 2021;275:120906. [PMID: 34139506 DOI: 10.1016/j.biomaterials.2021.120906] [Reference Citation Analysis]
35 Hummitzsch L, Zitta K, Fritze L, Monnens J, Vollertsen P, Lindner M, Rusch R, Hess K, Gruenewald M, Steinfath M, Fändrich F, Berndt R, Albrecht M. Effects of remote ischemic preconditioning (RIPC) and chronic remote ischemic preconditioning (cRIPC) on levels of plasma cytokines, cell surface characteristics of monocytes and in-vitro angiogenesis: a pilot study. Basic Res Cardiol 2021;116:60. [PMID: 34651218 DOI: 10.1007/s00395-021-00901-8] [Reference Citation Analysis]
36 Zheng PF, Zou QC, Chen LZ, Liu P, Liu ZY, Pan HW. Identifying patterns of immune related cells and genes in the peripheral blood of acute myocardial infarction patients using a small cohort. J Transl Med 2022;20:321. [PMID: 35864510 DOI: 10.1186/s12967-022-03517-1] [Reference Citation Analysis]
37 Arcari L, Cimino S, Filomena D, Monosilio S, Luongo F, Mancone M, Galea N, Francone M, Maestrini V, Agati L. Peak white blood cell count, infarct size and myocardial salvage in patients with reperfused ST-elevation myocardial infarction: a cardiac magnetic resonance study. J Cardiovasc Med (Hagerstown) 2021;22:228-30. [PMID: 32639330 DOI: 10.2459/JCM.0000000000001033] [Reference Citation Analysis]
38 Heger J, Hirschhäuser C, Bornbaum J, Sydykov A, Dempfle A, Schneider A, Braun T, Schlüter KD, Schulz R. Cardiomyocytes-specific deletion of monoamine oxidase B reduces irreversible myocardial ischemia/reperfusion injury. Free Radic Biol Med 2021;165:14-23. [PMID: 33476795 DOI: 10.1016/j.freeradbiomed.2021.01.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Steffens S, Van Linthout S, Sluijter JPG, Tocchetti CG, Thum T, Madonna R. Stimulating pro-reparative immune responses to prevent adverse cardiac remodelling: consensus document from the joint 2019 meeting of the ESC Working Groups of cellular biology of the heart and myocardial function. Cardiovascular Research 2020;116:1850-62. [DOI: 10.1093/cvr/cvaa137] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
40 Davidson SM, Andreadou I, Garcia-Dorado D, Hausenloy DJ. Shining the spotlight on cardioprotection: beyond the cardiomyocyte. Cardiovasc Res 2019;115:1115-6. [PMID: 30865272 DOI: 10.1093/cvr/cvz072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Sayour AA, Celeng C, Oláh A, Ruppert M, Merkely B, Radovits T. Sodium-glucose cotransporter 2 inhibitors reduce myocardial infarct size in preclinical animal models of myocardial ischaemia-reperfusion injury: a meta-analysis. Diabetologia 2021;64:737-48. [PMID: 33483761 DOI: 10.1007/s00125-020-05359-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Majka M, Kleibert M, Wojciechowska M. Impact of the Main Cardiovascular Risk Factors on Plasma Extracellular Vesicles and Their Influence on the Heart's Vulnerability to Ischemia-Reperfusion Injury. Cells 2021;10:3331. [PMID: 34943838 DOI: 10.3390/cells10123331] [Reference Citation Analysis]
43 Shi H, El Kazzi M, Liu Y, Gao A, Schroder AL, Vuong S, Young PA, Rayner BS, van Vreden C, King NJC, Witting PK. Multiplex analysis of mass imaging data: Application to the pathology of experimental myocardial infarction. Acta Physiol (Oxf) 2022;235:e13790. [PMID: 35080155 DOI: 10.1111/apha.13790] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Wang J, Yu L, Zhou A, Liu J, Wang K, Luo Y, Wang F. Non-Viral Gene Delivery Systems for Treatment of Myocardial Infarction: Targeting Strategies and Cardiac Cell Modulation. Pharmaceutics 2021;13:1520. [PMID: 34575595 DOI: 10.3390/pharmaceutics13091520] [Reference Citation Analysis]
45 Li J, Sun D, Li Y. Novel Findings and Therapeutic Targets on Cardioprotection of Ischemia/ Reperfusion Injury in STEMI. Curr Pharm Des 2019;25:3726-39. [PMID: 31692431 DOI: 10.2174/1381612825666191105103417] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Zuurbier CJ, Abbate A, Cabrera-Fuentes HA, Cohen MV, Collino M, De Kleijn DPV, Downey JM, Pagliaro P, Preissner KT, Takahashi M, Davidson SM. Innate immunity as a target for acute cardioprotection. Cardiovasc Res 2019;115:1131-42. [PMID: 30576455 DOI: 10.1093/cvr/cvy304] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 27.0] [Reference Citation Analysis]
47 Ključević N, Boban D, Milat AM, Jurić D, Mudnić I, Boban M, Grković I. Expression of Leukocytes Following Myocardial Infarction in Rats is Modulated by Moderate White Wine Consumption. Nutrients 2019;11:E1890. [PMID: 31416120 DOI: 10.3390/nu11081890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Foglio E, Pellegrini L, Russo MA, Limana F. HMGB1-Mediated Activation of the Inflammatory-Reparative Response Following Myocardial Infarction. Cells 2022;11:216. [PMID: 35053332 DOI: 10.3390/cells11020216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Cai Y, Kang L, Li H, Luo Y, Wen J, Gong Z, Chu Q, Qiu Y, Luo C, Chen K, Zhao X, Li R. Effects of Home-Based Baduanjin Exercise on Left Ventricular Remodeling in Patients With Acute Anterior ST-Segment Elevation Myocardial Infarction: Study Protocol for a Randomized Controlled Trial. Front Cardiovasc Med 2022;9:778583. [DOI: 10.3389/fcvm.2022.778583] [Reference Citation Analysis]
50 Boengler K, Schlüter KD, Schermuly RT, Schulz R. Cardioprotection in right heart failure. Br J Pharmacol 2020;177:5413-31. [PMID: 31995639 DOI: 10.1111/bph.14992] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
51 Vilahur G, Nguyen PH, Badimon L. Impact of Diabetes Mellitus on the Potential of Autologous Stem Cells and Stem Cell-Derived Microvesicles to Repair the Ischemic Heart. Cardiovasc Drugs Ther 2021. [PMID: 34251593 DOI: 10.1007/s10557-021-07208-9] [Reference Citation Analysis]
52 Yu Z, Ling Y, Xu Q, Cao Y, Tang S, Fu C. Blocking the A2B adenosine receptor alleviates myocardial damage by inhibiting spleen-derived MDSC mobilisation after acute myocardial infarction. Ann Med 2022;54:1616-26. [PMID: 35675334 DOI: 10.1080/07853890.2022.2084153] [Reference Citation Analysis]
53 Shah V, Shah J. Restoring Ravaged Heart: Molecular Mechanisms and Clinical Application of miRNA in Heart Regeneration. Front Cardiovasc Med 2022;9:835138. [DOI: 10.3389/fcvm.2022.835138] [Reference Citation Analysis]
54 Rurik JG, Aghajanian H, Epstein JA. Immune Cells and Immunotherapy for Cardiac Injury and Repair. Circ Res 2021;128:1766-79. [PMID: 34043424 DOI: 10.1161/CIRCRESAHA.121.318005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Ong SB, Kwek XY, Katwadi K, Hernandez-Resendiz S, Crespo-Avilan GE, Ismail NI, Lin YH, Yap EP, Lim SY, Ja KPMM, Ramachandra CJA, Tee N, Toh JJ, Shim W, Wong P, Cabrera-Fuentes HA, Hausenloy DJ. Targeting Mitochondrial Fission Using Mdivi-1 in A Clinically Relevant Large Animal Model of Acute Myocardial Infarction: A Pilot Study. Int J Mol Sci 2019;20:E3972. [PMID: 31443187 DOI: 10.3390/ijms20163972] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
56 Patil M, Saheera S, Dubey PK, Kahn-Krell A, Kumar Govindappa P, Singh S, Tousif S, Zhang Q, Lal H, Zhang J, Qin G, Krishnamurthy P. Novel Mechanisms of Exosome-Mediated Phagocytosis of Dead Cells in Injured Heart. Circ Res 2021;129:1006-20. [PMID: 34623174 DOI: 10.1161/CIRCRESAHA.120.317900] [Reference Citation Analysis]
57 Ma Y. Role of Neutrophils in Cardiac Injury and Repair Following Myocardial Infarction. Cells 2021;10:1676. [PMID: 34359844 DOI: 10.3390/cells10071676] [Reference Citation Analysis]
58 Baehr A, Klymiuk N, Kupatt C. Evaluating Novel Targets of Ischemia Reperfusion Injury in Pig Models. Int J Mol Sci 2019;20:E4749. [PMID: 31557793 DOI: 10.3390/ijms20194749] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
59 Yang D, Liu HQ, Liu FY, Tang N, Guo Z, Ma SQ, An P, Wang MY, Wu HM, Yang Z, Fan D, Tang QZ. The Roles of Noncardiomyocytes in Cardiac Remodeling. Int J Biol Sci 2020;16:2414-29. [PMID: 32760209 DOI: 10.7150/ijbs.47180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Casin KM, Calvert JW. Dynamic Regulation of Cysteine Oxidation and Phosphorylation in Myocardial Ischemia-Reperfusion Injury. Cells 2021;10:2388. [PMID: 34572037 DOI: 10.3390/cells10092388] [Reference Citation Analysis]
61 Lin Z, Xu H, Chen Y, Zhang X, Yang J. Identification of potential biomarkers and immune-related pathways related to immune infiltration in patients with acute myocardial infarction. Transpl Immunol 2022;:101652. [PMID: 35764238 DOI: 10.1016/j.trim.2022.101652] [Reference Citation Analysis]
62 Vujic A, Natarajan N, Lee RT. Molecular mechanisms of heart regeneration. Semin Cell Dev Biol 2020;100:20-8. [PMID: 31587963 DOI: 10.1016/j.semcdb.2019.09.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
63 Li Y, Deng S, Wang X, Huang W, Chen J, Robbins N, Mu X, Essandoh K, Peng T, Jegga AG, Rubinstein J, Adams DE, Wang Y, Peng J, Fan GC. Sectm1a deficiency aggravates inflammation-triggered cardiac dysfunction through disruption of LXRα signalling in macrophages. Cardiovasc Res 2021;117:890-902. [PMID: 32170929 DOI: 10.1093/cvr/cvaa067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Nikolaou PE, Mylonas N, Makridakis M, Makrecka-Kuka M, Iliou A, Zerikiotis S, Efentakis P, Kampoukos S, Kostomitsopoulos N, Vilskersts R, Ikonomidis I, Lambadiari V, Zuurbier CJ, Latosinska A, Vlahou A, Dimitriadis G, Iliodromitis EK, Andreadou I. Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect? Basic Res Cardiol 2022;117:27. [PMID: 35581445 DOI: 10.1007/s00395-022-00934-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Askari N, Lipps C, Voss S, Staubach N, Grün D, Klingenberg R, von Jeinsen B, Wolter JS, Kriechbaum S, Dörr O, Nef H, Liebetrau C, Hamm CW, Keller T. Circulating Monocyte Subsets Are Associated With Extent of Myocardial Injury but Not With Type of Myocardial Infarction. Front Cardiovasc Med 2021;8:741890. [PMID: 34796212 DOI: 10.3389/fcvm.2021.741890] [Reference Citation Analysis]
66 Flamant M, Mougenot N, Balse E, Le Fèvre L, Atassi F, Gautier EL, Le Goff W, Keck M, Nadaud S, Combadière C, Boissonnas A, Pavoine C. Early activation of the cardiac CX3CL1/CX3CR1 axis delays β-adrenergic-induced heart failure. Sci Rep 2021;11:17982. [PMID: 34504250 DOI: 10.1038/s41598-021-97493-z] [Reference Citation Analysis]
67 Bhagat S, Biswas I, Alam MI, Khan M, Khan GA. Key role of Extracellular RNA in hypoxic stress induced myocardial injury. PLoS One 2021;16:e0260835. [PMID: 34882718 DOI: 10.1371/journal.pone.0260835] [Reference Citation Analysis]
68 Shah M, He Z, Rauf A, Kalkhoran SB, Heiestad CM, Stensløkken KO, Parish CR, Soehnlein O, Arjun S, Davidson SM, Yellon D. Extracellular histones are a target in myocardial ischaemia reperfusion injury. Cardiovasc Res 2021:cvab139. [PMID: 33878183 DOI: 10.1093/cvr/cvab139] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Saludas L, Oliveira CC, Roncal C, Ruiz-Villalba A, Prósper F, Garbayo E, Blanco-Prieto MJ. Extracellular Vesicle-Based Therapeutics for Heart Repair. Nanomaterials (Basel) 2021;11:570. [PMID: 33668836 DOI: 10.3390/nano11030570] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
70 Mouton AJ, Li X, Hall ME, Hall JE. Obesity, Hypertension, and Cardiac Dysfunction: Novel Roles of Immunometabolism in Macrophage Activation and Inflammation. Circ Res 2020;126:789-806. [PMID: 32163341 DOI: 10.1161/CIRCRESAHA.119.312321] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 20.5] [Reference Citation Analysis]
71 Ziegler M, Wang X, Peter K. Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target. Cardiovasc Res 2019;115:1178-88. [PMID: 30906948 DOI: 10.1093/cvr/cvz070] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 15.5] [Reference Citation Analysis]
72 Shah M, Yellon DM, Davidson SM. The Role of Extracellular DNA and Histones in Ischaemia-Reperfusion Injury of the Myocardium. Cardiovasc Drugs Ther 2020;34:123-31. [PMID: 32062794 DOI: 10.1007/s10557-020-06946-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
73 Yang T, Long T, Du T, Chen Y, Dong Y, Huang ZP. Circle the Cardiac Remodeling With circRNAs. Front Cardiovasc Med 2021;8:702586. [PMID: 34250050 DOI: 10.3389/fcvm.2021.702586] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Chatterjee M. Atypical Roles of the Chemokine Receptor ACKR3/CXCR7 in Platelet Pathophysiology. Cells 2022;11:213. [PMID: 35053329 DOI: 10.3390/cells11020213] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 Lieder HR, Irmert A, Kamler M, Heusch G, Kleinbongard P. Sex is no determinant of cardioprotection by ischemic preconditioning in rats, but ischemic/reperfused tissue mass is for remote ischemic preconditioning. Physiol Rep 2019;7:e14146. [PMID: 31210033 DOI: 10.14814/phy2.14146] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
76 Van Linthout S, Tschöpe C. The Quest for Antiinflammatory and Immunomodulatory Strategies in Heart Failure. Clin Pharmacol Ther 2019;106:1198-208. [PMID: 31544235 DOI: 10.1002/cpt.1637] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
77 Zhao W, Zhao J, Rong J. Pharmacological Modulation of Cardiac Remodeling after Myocardial Infarction. Oxid Med Cell Longev 2020;2020:8815349. [PMID: 33488934 DOI: 10.1155/2020/8815349] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
78 Zang X, Zhou J, Zhang X, Han Y, Chen X. Ischemia Reperfusion Injury: Opportunities for Nanoparticles. ACS Biomater Sci Eng 2020;6:6528-39. [PMID: 33320610 DOI: 10.1021/acsbiomaterials.0c01197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
79 Deng J. Advanced research on the regulated necrosis mechanism in myocardial ischemia-reperfusion injury. Int J Cardiol 2021;334:97-101. [PMID: 33930510 DOI: 10.1016/j.ijcard.2021.04.042] [Reference Citation Analysis]